Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ZIOPHARM Oncology Inc

+ Add to Watchlist

WEK:GR

8.393 EUR 0.041 0.49%

As of 09:44:52 ET on 05/28/2015.

Snapshot for ZIOPHARM Oncology Inc (WEK)

Open: 8.455 Day's Range: 8.393 - 8.618 Volume: 0
Previous Close: 8.434 52wk Range: 1.863 - 13.352 1-Yr Rtn: +220.34%

Stock Chart for WEK

No chart data available.
  • WEK:GR 8.393
  • 1D
  • 1M
  • 1Y
8.434
Interactive WEK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for WEK

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.8920
Est. PEG Ratio -
Market Cap (M EUR) 1,076.26
Shares Outstanding (M) 128.23
30 Day Average Volume 968
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for WEK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for WEK

ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs.

Laurence James Neil CooperChief Executive OfficerCaesar J BelbelExec VP/Chief Legal Ofcr/Secy
Kevin G LafondVP:Finance/Chief Accounting Ofcr
More Company Profile & Key Executives for WEK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil